Interferon α 2b Pharmacovigilance Study

NCT01841775 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: interferon α 2b + ribavirin

Sponsor

The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)

Collaborators

[object Object]
[object Object]